Lumosa Therapeutics Co. Ltd Financials

Market Capitalization TW$24.17 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	-54.42
Forward PE
Price to Sales TTM	TW$554.62
Price to Book MRQ	TW$13.36
Enterprise to Revenue	538.87
Enterprise to EBITDA	-62.05

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	45.24%
Operating Margin	-1196.37%
Return on Assets TTM	-13.38%
Return on Equity TTM	-26.98%

Income Statement

Revenue TTM	TW$43,587,000
Revenue per Share TTM	TW$0.27
Quarterly Revenue Growth	99.30%
Gross Profit TTM	TW$21,524,000
EBITDA	TW$-378,540,992
Net Income to Common TTM	TW$-413,351,008
Diluted EPS TTM	TW$-2.53
Quarterly Earnings Growth YoY	99.33%

Balance Sheet

Total Cash MRQ	TW$1,270,450,048
Total Cash per Share MRQ	TW$7.53
Total Debt MRQ	TW$
Total Debt to Equity MRQ	0.66
Current Ratio MRQ	6.61
Book Value per Share MRQ	TW$10.74

Cash Flow

Operating Cash Flow TTM	TW$-297,678,016
Levered Free Cash Flow TTM	TW$-169,835,632

6535 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	168,896,825
Float Shares	89,241,638
Avg 10 Volume	177,980
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	47.82%
% Held by Institutions	5.82%

Stock Price Summary

Beta	-0.02
Fifty Two Week Low	TW$129.00
Fifty Two Week High	TW$400.00
Fifty Two Week Change	-48.06%
Day 50 MA	TW$159.14
Day 200 MA	TW$230.57

Dividends and Splits

Forward Annual Dividend Rate	TW$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	TW$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date